BCV
HAE icon

Banque Cantonale Vaudoise’s Haemonetics HAE Stock Holding History

Banque Cantonale Vaudoise’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,451
Closed -$404K – 1209
2022
Q3 		$404K Buy
+5,451
New +$391K 0.02% 524

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Banque Cantonale Vaudoise's HAE Position: Q4 2022 in Review

Banque Cantonale Vaudoise sold out of Haemonetics (HAE) in Q4 2022, closing a stake of 5,451 shares — an estimated $404K sold.

Banque Cantonale Vaudoise first reported a position in HAE in Q3 2022 and held it in 1 quarter. The position peaked at $404K in Q3 2022. 294 funds tracked by Wall St. Rank hold HAE as of Q4 2022.

  • Banque Cantonale Vaudoise reported no remaining Haemonetics position as of Q4 2022 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 5,451 Haemonetics shares in Q4 2022, an estimated $404K.
  • Banque Cantonale Vaudoise first reported a position in Haemonetics in Q3 2022 and held it in 1 quarter.
  • Banque Cantonale Vaudoise's Haemonetics position peaked at $404K in Q3 2022.
  • 294 funds tracked by Wall St. Rank held Haemonetics as of Q4 2022.

Based on Banque Cantonale Vaudoise's 13F filing for Q4 2022, filed 10 Feb 2023.